Free Trial

Neumora Therapeutics (NMRA) News Today

Neumora Therapeutics logo
$0.70 +0.00 (+0.51%)
As of 11:11 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NMRA Latest News

Neumora Therapeutics, Inc. stock logo
Softbank Group CORP. Has $69.34 Million Position in Neumora Therapeutics, Inc. (NASDAQ:NMRA)
Softbank Group CORP. decreased its position in Neumora Therapeutics, Inc. (NASDAQ:NMRA - Free Report) by 13.3% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 6,541,190 shares of the company's stock after selling 1,005,726 shares during th
Neumora Therapeutics, Inc. stock logo
HC Wainwright Has Pessimistic Outlook of NMRA Q2 Earnings
Neumora Therapeutics, Inc. (NASDAQ:NMRA - Free Report) - Equities research analysts at HC Wainwright decreased their Q2 2025 EPS estimates for Neumora Therapeutics in a research report issued on Tuesday, May 13th. HC Wainwright analyst D. Tsao now expects that the company will earn ($0.44) per sh
Neumora Therapeutics, Inc. stock logo
Q2 EPS Forecast for Neumora Therapeutics Raised by Analyst
Neumora Therapeutics, Inc. (NASDAQ:NMRA - Free Report) - Stock analysts at William Blair upped their Q2 2025 EPS estimates for shares of Neumora Therapeutics in a report issued on Tuesday, May 13th. William Blair analyst M. Minter now forecasts that the company will post earnings per share of ($0
Neumora Therapeutics, Inc. stock logo
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Shares Sold by Price T Rowe Associates Inc. MD
Price T Rowe Associates Inc. MD trimmed its holdings in Neumora Therapeutics, Inc. (NASDAQ:NMRA - Free Report) by 94.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 32,548 shares of the company's stock afte
Neumora Therapeutics, Inc. stock logo
Needham & Company LLC Reiterates "Buy" Rating for Neumora Therapeutics (NASDAQ:NMRA)
Needham & Company LLC reissued a "buy" rating and issued a $5.00 target price on shares of Neumora Therapeutics in a research note on Tuesday.
Neumora Therapeutics, Inc. stock logo
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Stock Holdings Lessened by Orbimed Advisors LLC
Orbimed Advisors LLC lessened its stake in shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA - Free Report) by 46.3% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 804,996 shares of the company's stock after selling 695,004 shares during the period. Orbimed
Neumora Therapeutics, Inc. stock logo
Neumora Therapeutics (NASDAQ:NMRA) Posts Earnings Results, Misses Expectations By $0.02 EPS
Neumora Therapeutics (NASDAQ:NMRA - Get Free Report) issued its earnings results on Monday. The company reported ($0.42) EPS for the quarter, missing analysts' consensus estimates of ($0.40) by ($0.02).
Neumora Therapeutics, Inc. stock logo
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Average Rating of "Hold" by Analysts
Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA - Get Free Report) have received a consensus rating of "Hold" from the nine analysts that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, five have assigned a hold ratin
Neumora Therapeutics, Inc. stock logo
Schonfeld Strategic Advisors LLC Increases Stake in Neumora Therapeutics, Inc. (NASDAQ:NMRA)
Schonfeld Strategic Advisors LLC boosted its stake in shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA - Free Report) by 273.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 521,013 shares of the company's sto
Neumora Therapeutics, Inc. stock logo
Neumora Therapeutics (NMRA) Expected to Announce Quarterly Earnings on Tuesday
Neumora Therapeutics (NASDAQ:NMRA) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-neumora-therapeutics-inc-stock/)
Neumora Therapeutics, Inc. stock logo
Capital International Investors Raises Stake in Neumora Therapeutics, Inc. (NASDAQ:NMRA)
Capital International Investors boosted its holdings in Neumora Therapeutics, Inc. (NASDAQ:NMRA - Free Report) by 692.1% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 3,700,359 shares of the company's stock after buying an additional 3,233,179 shares d
Neumora Therapeutics, Inc. stock logo
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Consensus Rating of "Hold" by Analysts
Neumora Therapeutics, Inc. (NASDAQ:NMRA - Get Free Report) has been assigned a consensus recommendation of "Hold" from the nine analysts that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and thre
Neumora Therapeutics, Inc. stock logo
Neumora Therapeutics' (NMRA) "Buy" Rating Reaffirmed at Needham & Company LLC
Needham & Company LLC restated a "buy" rating and issued a $5.00 price objective on shares of Neumora Therapeutics in a research note on Thursday.
Neumora Therapeutics, Inc. stock logo
Neumora Therapeutics' (NMRA) "Underperform" Rating Reaffirmed at Bank of America
Bank of America reaffirmed an "underperform" rating and set a $1.00 price objective (down previously from $7.00) on shares of Neumora Therapeutics in a research report on Wednesday.
Get Neumora Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NMRA and its competitors with MarketBeat's FREE daily newsletter.

NMRA Media Mentions By Week

NMRA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NMRA
News Sentiment

1.02

1.03

Average
Medical
News Sentiment

NMRA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NMRA Articles
This Week

3

8

NMRA Articles
Average Week

Get Neumora Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NMRA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:NMRA) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners